Sanofi's Tolebrutinib Granted FDA Priority Review For Non-Relapsing Secondary Progressive MS, Targeting Smoldering Neuroinflammation
Trump to Nominate Acting CDC Director Monarez to Lead Agency - Report
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty
Trump's Tariff Moves: Market Stabilization Amid Uncertainty and the Road Ahead
23andMe Files for Bankruptcy, CEO and Co-founder Wojcicki Resigns